Rahat Ali, Mohammad Islamuddin, Shams Tabrez, Mohammed Alsaweed, Mohammed A Alaidarous, Bader Mohammed Alshehri, Saeed Banawas, Abdul Aziz Bin Dukhyil, Abdur Rub
Visceral leishmaniasis (VL) is caused by a protozoan parasite, Leishmania donovani (L. donovani). It affects around 1-2 million people around the world annually. There is an urgent need to investigate new medicament of it due to difficult method of drug administration, long period of treatment, high cost of the drug, adverse side-effects, low efficacy and development of parasite resistance to the available drugs. Medicinal plants have also been used for the treatment of different diseases in traditional system of medicines due to their holistic effects...
November 2021: Biomedicine & Pharmacotherapy